Replies to post #116286 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

LoL! RGBP has had 10 or more 350% Runs this year And many 50% and up runs last year along with 2 big Fun 1,000% to 20,000% Runs last year making RGBP Traders
So much
Additional
Dollars!
6 and 7 figure RGBP traders traders making much Bank!$$$$$ So Sad! LoL!
KOO’s got the answers! Bring on the partners!
Contact RGBP:
https://regenbiopharmainc.com/about-us/
1 IND cleared and 2 INDs submitted with the FDA.
Diverse pre-clinical pipeline including platform technologies .
Strong intellectual property protected by multiple patents
Pipeline:
https://regenbiopharmainc.com/product-pipeline/
Big boys checking out DuraCAR now?
https://www.prnewswire.com/news-releases/regen-biopharma-inc-progresses-its-duracar-therapeutic-301682553.html
Big boys big events
Ongoing Agreement With Eli Lilly Leads to Discovery of Several New Small Molecule Drugs
https://www.hvst.com/posts/ongoing-agreement-with-eli-lilly-leads-to-discovery-of-several-new-small-molecule-drugs-wm4T1ZDp

Dr. KOO’s and his Dream Team has done so much to get RGBP current and where it is at today!
LoL! Dr. David KOO’s is a Business Leader!
KOO’s owns 38+% or 169+ million shares of RGBP preferred shares RGBPP!
https://www.marketscreener.com/business-leaders/David-Raymond-Koos-06H0YV-E/biography/
Many of us have made much bank trading RGBPP preferred shares as well as RGBP. Years ago Dr. KOO’s gave us free RGBPP preferred shares as a dividend. Maybe he will do the same again or with sybleu.
When stock is spun off and given to shareholders as a stock dividend the Nakedshorts will be responsible to deliver the dividends on there short shares. It’s a very good way to trap the shorts!
Latest RGBP developments
https://www.userwalls.news/n/regen-biopharma-begins-experiments-validating-proprietary-car-cell-therapy-3813657/

https://www.bloomberg.com/press-releases/2022-08-25/regen-biopharma-develops-novel-means-of-using-car-t-cell-immunotherapy-to-attack-solid-tumors

https://docoh.com/news/benzinga/28638284/regen-biopharma-develops?fromCompany=1589150

https://www.nasdaq.com/press-release/regen-biopharma-inc.-files-provisional-patent-application-on-second-generation

Dr. David KOO’s has 169 Million reasons for making RGBP Great Again!
KOO’s owns 169+ million shares of RGBPP preferred shares or 169 million reasons to see that RGBP is successful.
https://www.marketscreener.com/business-leaders/David-Raymond-Koos-06H0YV-E/biography/
RGBP on the Fast Track!
Things looking up here:
San Diego, CA, March 30, 2022: Regen BioPharma, Inc. received communication from the U.S. Patent Office that certain claims in its application #15/820,324 entitled, “Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans” have been allowed. $RGBP $RGBPP 1:39 PM · Mar 30, 2022·[/b
]


On the next Big Fun RGBP Run with the right News, Deal, Partner or Buyout RGBP should get get the mother of all the RGBP Naked Short Squeezes IMO!

Now RGBP has much more going for us!
Regen BioPharma Inc's Company Profile
Business Description
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.
Anyone can contact KOO’s but you have to leave a call back number that helps keep the Bull $hitters that don’t want to be identified from wasting his time!
Telephone: [phone] ext: 800
Fax: [phone]
Email: [e-mail]